Moderna stock surges 6% as its vaccine produces antibodies against Delta variant

Moderna (MRNA.US) stock rose almost 6% after the drugmaker announced that its Covid-19 vaccine produced protective antibodies against the contagious delta variant. The mRNA vaccine produced neutralizing antibodies against all variants tested, including the delta, beta and eta, the company said in a statement. Additionally, news that India approved Moderna's vaccine for restricted emergency use also lifted sentiment towards the stock.

Moderna (MRNA.US) stock price rose sharply during today's session and hit a new all-time high at $238.22 which coincides with 127.2 external Fibonacci retracement. If the current sentiment prevails then the next target for bulls is located around $247.63 and is marked by 161.8 external Fibonacci retracement. Source: xStation5